tradingkey.logo

Cross Country Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 7, 2025 1:26 AM
  • Cross Country Healthcare Inc CCRN.OQ reported a quarterly adjusted loss of 1 cent​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 10 cents. The mean expectation of seven analysts for the quarter was for earnings of 5 cents per share. Wall Street expected results to range from 3 cents to 9 cents per share.

  • Revenue fell 19.3% to $274.07 million from a year ago; analysts expected $290.37 million.

  • Cross Country Healthcare Inc's reported EPS for the quarter was a loss of 20 cents​.

  • The company reported a quarterly loss of $6.66 million.

  • Cross Country Healthcare Inc shares had fallen by 1.6% this quarter and lost 29.3% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 34.4% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 8 "hold" and no "sell" or "strong sell." The average consensus recommendation for the employment services peer group is "buy."

  • Wall Street's median 12-month price target for Cross Country Healthcare Inc is $18.61, about 29.6% above its last closing price of $13.10

This summary was machine generated from LSEG data August 7 at 01:25 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

0.05

-0.01

Missed

Mar. 31 2025

0.06

0.06

Met

Dec. 31 2024

0.12

0.04

Missed

Sep. 30 2024

0.10

0.12

Beat

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI